Article Details

Eiger Biopharmaceuticals (NASDAQ:EIGR) Upgraded by ValuEngine to Strong-Buy

Retrieved on: 2018-10-25 00:30:00

Tags for this article:

Click the tags to see associated articles and topics

Eiger Biopharmaceuticals (NASDAQ:EIGR) Upgraded by ValuEngine to Strong-Buy. View article details on hiswai:

Excerpt

<div><b>Acadian Asset Management</b> LLC now owns 56,266 shares of the biotechnology company's stock worth $687,000 after buying an additional 35,518 ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up